Share OutstandingThe amount of shares outstanding right now or in the future doesn't really matter right now. What matters is will NRM8499 be successful. Also will the company be able to finance it on its own. This is a disease modifying solution for Alzheimer's, it is not an attempt to treat the symptoms. At the present time there is absolutely nothing that is effective for Alzheimer's even the approved prescription drugs authorized by the FDA do not work. If you don't believe me just go to the National Institutes of Health website and see for yourself.
Some comments on costs associated with Alzheimer's:
The global care cost for people with Alzheimer's disease and other forms of dementia is estimated at US$601 billion for the year 2010, which is more than 1percent of the global GDP in the same year, according to a report released Tuesday.
The report by the Alzheimer's Disease International (ADI) says the care for an estimated 35.6 million people with Alzheimer's disease and other dementias,when viewed as a country, would be the world's 18th largest economy somewhere between Turkey and Indonesia; when viewed as a company, the cost would be more than the annual revenue of Wal-Mart ($414 billion) and Exxon Mobil ($311billion).
The Chicago-based Alzheimer’s Association also released a 2010 report saying that the care cost for 5.3 million Americans with Alzheimer's disease is $172billion a year. Per capita, the cost for each person with the disease is $32,453 annually.
Although the United States pays a high price for the care given patients with Alzheimer's disease, the Alzheimer's disease mortality is on the rise.The AA report says that Alzheimer's deaths increased 46.1 percent from2000 to 2006.
So, you can see if BLU is successful, the payoff will be so huge that it is impossible to calculate. It will be necessary to have a large float just to keep the price under control. The stock price will rise to unimaginable heights.
Also, Kiacta on its own will yield a great stock price, and don't forget to add in Vivimind. So if the outstanding float bothers you, it is not a good reason to bypass this tremendous opportunity.
Remember, it is impossible to calculate the future value and stock price if the company is successful with NRM8499.